Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Wierda

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Leukemia|January 25, 2017
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemiaE J Murphy, D S Neuberg, L Z Rassenti, et al.
Blood|January 22, 2020
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomasS A Srour, H Singh, J McCarty, et al.
Leukemia|December 8, 2015
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL studyA C Rawstron, C Fazi, A Agathangelidis, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Leukemia|January 25, 2017
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemiaE J Murphy, D S Neuberg, L Z Rassenti, et al.
Blood|January 22, 2020
Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomasS A Srour, H Singh, J McCarty, et al.
Leukemia|December 8, 2015
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL studyA C Rawstron, C Fazi, A Agathangelidis, et al.
Pageof 4